1. Home
  2. PECO vs BLLN Comparison

PECO vs BLLN Comparison

Compare PECO & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phillips Edison & Company Inc.

PECO

Phillips Edison & Company Inc.

N/A

Current Price

$40.43

Market Cap

5.2B

Sector

Real Estate

ML Signal

N/A

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$89.79

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PECO
BLLN
Founded
1991
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.6B
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
PECO
BLLN
Price
$40.43
$89.79
Analyst Decision
Buy
Buy
Analyst Count
14
8
Target Price
$43.46
★ $128.29
AVG Volume (30 Days)
★ 968.8K
654.6K
Earning Date
10-26-2026
11-04-2026
Dividend Yield
★ 3.42%
N/A
EPS Growth
74.51
★ 103.40
EPS
★ 1.05
0.81
Revenue
★ $726,594,000.00
$305,112,000.00
Revenue This Year
$5.19
$51.66
Revenue Next Year
$6.41
$24.74
P/E Ratio
★ $38.48
$111.36
Revenue Growth
9.86
★ 99.97
52 Week Low
$34.49
$61.96
52 Week High
$44.38
$150.44

Technical Indicators

Market Signals
Indicator
PECO
BLLN
Relative Strength Index (RSI) 56.04 30.16
Support Level $38.78 $66.44
Resistance Level $40.49 $97.18
Average True Range (ATR) 0.69 6.58
MACD -0.07 -2.77
Stochastic Oscillator 42.91 10.93

Price Performance

Historical Comparison
PECO
BLLN

About PECO Phillips Edison & Company Inc.

Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interest, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on a market of expertise designed to optimize property value and consistently deliver a great shopping experience.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: